Stay updated on Risankizumab in PsA Patients: Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision changed from Revision: v3.6.3 to Revision: v3.6.4. This appears to be a general site update with no change to the study details or user actions.
    Difference
    0.0%
    Check dated 2026-07-25T17:53:41.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating a small update to the page's documentation/history.
    Difference
    0.0%
    Check dated 2026-07-04T09:23:32.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2, indicating a newer revision of the study documentation.
    Difference
    0.0%
    Check dated 2026-06-27T06:50:40.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The study page now displays a recruitment-closed notice and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) to guide users.
    Difference
    0.1%
    Check dated 2026-06-12T23:51:32.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The revision line at the bottom shows Revision: v3.5.5, replacing the previous v3.5.4.
    Difference
    0.0%
    Check dated 2026-06-05T22:08:18.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    The Ukraine location entry was updated to standardize the location as Kharkiv Oblast, Ukraine. The city line now reads Kharkiv, Kharkiv Oblast, Ukraine, 61039.
    Difference
    0.0%
    Check dated 2026-05-29T23:08:18.000Z thumbnail image

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.